ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells

These results, in accordance with our previous findings, support the role of ZNF224 in imatinib responsiveness and shed new insights into potential therapeutic use of ZNF224 in imatinib-resistant chronic myelogenous leukemia.